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ABSTRACT 
Cassia singueana Del. (Fabaceae) is a tropical plant species widely distributed across northern Nigeria. It is 
used by traditional herbalists in the treatment of ulcer, diabetes and other diseases. In this work, the n-hexane 
leaf extract of C. singueana was fractionated and purified by column chromatography using n-hexane, CHCl3, 
and EtOAc. This process led to the isolation of five (5) compounds namely, stigmasterol (1), stigmast-4-en-3-
one (2a), stigmast-4, 22-dien-3-one (2b), 1-heneicosanol (3) and hexyl heneicosanoate (4). Compounds 2a and 
2b were isolated as mixture. The structures of the isolated compounds were elucidated using 1D and 2D NMR 
spectral analysis and comparison of the spectral data with literature values was undertaken.  
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INTRODUCTION 
Cassia species are used worldwide as 
traditional medicines and in commercial 
pharmaceuticals (Lim, 2012, Ayo, 2010). They 
spread across tropical and sub-tropical regions 
(Bhalerao and Kelkar, 2012). Cassia singueana 
Del. (Fabaceae), commonly known as winter 
Cassia is a shrub or tree with numerous medicinal 
values across Africa (Hiben, et. al., 2016) including 
Nigeria were it is widely found in the northern part 
of the country. The leaf juice is traditionally used 
to treat syphilis, ulcer, malaria, pneumonia, snake 
bite and eye infection (Schmelzer et. al., 2008). 
Furthermore, in northern Nigeria, the leaf is used to 
treat ulcer (Ode and Asuzu, 2011), diabetes 
mellitus (Etuk et. al., 2010 ) and to enhance blood 
circulation in nursing mothers (Ifeanyi and Ode, 
2012). Studies have demonstrated that leaf extract 
of C. singueana possess anti-ulcer (Ode, 2011; Ode 
et. al.; Ode and Asuzu, 2011; Ode and Onakpa, 
2010), antimalarial (Hiben et. al., 2016; Saidu et. 
al., 2011), antioxidant (Ibrahim and Islam, 2013; 
Ifeanyi and Ode, 2012; Mebrahtom, 2007) 
activities. In terms of the compounds isolated from 
this plant, only luteolin has been reported from the 
leaf extract of C. singueana (Ode and Asuzu, 
2011). In this study, we describe the isolation and 
structural elucidation of stigmasterol (1), stigmast-
4-en-3-one (2a), stigmasta-4, 22-dien-3-one (2b), 
1-heneicosanol (3) and hexyl heneicosanoate (4) 
(Fig. 1) from the n-hexane leaf extract of C. 
singueana. 
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Hexyl heneicosanoate (4)  
Fig. 1: Compounds Isolated from n-Hexane Leaf Extract of C. Singueana 
 
EXPERIMENTAL 
General Experimental Procedure 
The NMR spectra were recorded on a 
Bruker Avance instrument, (400 MHz for 1H and 
100 MHz for 13C) using CDCl3 as solvent. Silica 
gel 60 (70-230 mesh, for Column Chromatography 




The leaf part of C. singueana was 
collected in August, 2014, from Kumuyel, Alkaleri 
Local Government Area of Bauchi State, Nigeria. 
The plant was identified by Mr. Baha’uddeen Said 
Adam of the Department of Plant Biology, Bayero 
University Kano. Voucher specimen, BUKHAN 
0316 was then deposited at the Herbarium of 
Department of Plant Biology, Bayero University 
Kano, Nigeria. 
 
Extraction and Isolation 
The air-dried and powdered leaf of C. 
singueana (200 g) was macerated with n-hexane 
for three (3) days (3 × 4 L) at room temperature. 
The extract was filtered and concentrated under 
reduced pressure to yield the n- hexane crude 
extract (CSLH, 3.2 g, 1.6%). The n-hexane crude 
extract (CSLH, 3 g, 1.50%) was subjected to 
Column Chromatography (silica gel, 120 g) using 
n-hexane, n-hexane/ CHCl3, CHCl3, n-hexane 
/EtOAc, EtOAc in a polarity gradient manner. 
Fractions were pooled together base on their TLC 
profile to obtain thirty fractions (CSLH 1- CSLH 
30). Fraction CSLH 8 - 17 (1.1 g) was loaded on a 
silica gel column chromatography (70 g) and eluted 
using n-hexane/CHCl3/EtOAc in an increasing 
polarity to give fifteen sub-fractions. Sub-fractions 
5-10 were combined and further purified on 
column chromatography to yield compound (1) and 
compound (3) as white amorphous substances. 
Sub-fractions 11 – 15 were pooled together and re-
chromatographed by column chromatography using 
n- hexane, n-hexane/CHCl3, CHCl3, CHCl3/EtOAc 
in gradient manner, affording compound (2) as 
white amorphous substance. Fraction CSLH 18 - 
30 (0.8 g) was absorbed on silica gel (70 - 230 
mesh, 55 g) and eluted in n-hexane/CHCl3/EtOAc 
in a step wise gradient manner, to give compound 
(4) as white amorphous substance. Structure of 
compounds 1-4 (Fig. 1) were identified using 
spectroscopic methods and comparison of the data 
obtained with published literature was undertaken.       
Compound 1: yield, 25 mg; 1H NMR (400 
MHz, CDCl3): δ 0.65, 0.77, 0.80, 0.84, 0.98, 1.03, 
(each 3H, s, CH3), 2.02 (1H, m, H-20), 3.57 (1H, 
m, H-3), 5.20 (1H, dd,  J = 15.2, 8.8 Hz, H-22), 
5.06 (1H, dd, J = 15.2, 8.8 Hz, H-23), 5.38 (1H, d, 
J = 5.2 Hz, H-6); 13C NMR (100 MHz, CDCl3): δ 
12.2 (C-29), 12.0 (C-18), 19.0 (C-27), 19.4 (C-19), 
21.2 (C-11), 21.2 (C-26), 21.2 (C-21), 24.4 (C-15), 
25.4 (C-28), 29.0 (C-16), 31.6 (C-2), 31.9 (C-7), 
32.0 (C-8/C-25), 36.4 (C-10), 37.2 (C-1), 40.5 (C-
12), 39.7 (C-20), 42.2 (C-13), 42.2 (C-4), 50.1 (C-
9), 51.3 (C-24), 56.0 (C-17), 56.8 (C-14), 71.8 (C-
3), 121.5 (C-6), 129.2 (C-23), 138.4 (C-22), 140.8 
(C-5). 
Compound 2a: yield, 18 mg; 1HNMR 
(400 MHz, CDCl3): δ 0.71 (3H, s, H-18), 0.82 (3H, 
d, J = 6.8 Hz, H-27), 0.84 (3H, d, J = 6.8 Hz, H-
26), 0.85 (3H, m, H-29), 0.92 (3H, d, J = 6.5 Hz, 
H-21), 1.18 (3H, s, H-19), 5.72 (1H, s, H-4). 13C 
NMR (100 MHz, CDCl3): δ 11.9 (C-29), 12.2 (C-
18), 17.3 (C-19), 18.7 (C-21), 19.0 (C27), 19.8 (C-
26), 21.1 (C-11), 23.0 (C-28), 24.1 (C-15), 26.0 (C-
23), 28.2 (C-16), 29.1 (C-25), 32.0 (C-22), 32.9 (C-
7), 33.8 (C-6), 33.9 (C-2), 35.6 (C-1), 35.6 (C-8), 
36.1 (C-20), 38.6 (C- 10), 42.3 (C-13), 45.8 (C-24), 
53.8 (C-9), 55.8 (C-14), 55.9 (C-17), 123.7 (C-4), 
171.8 (C-5), 199.7 (C-3).     
Compound 2b: yield, 18 mg; 1HNMR 
(400 MHz, CDCl3): δ 0.73 (3H, s, H-18), 0.80 (3H, 
d, J = 6.0 Hz, H-26), 0.81 (3H, m, H-29), 0.85 (3H, 
d, J = 6.0 Hz, H-27), 1.02 (3H, d, J = 7.5 Hz, H-
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21), 1.18 (3H, s, H-19), 5.03 (1H, dd, J = 9.0, 15.5 
Hz, H-23), 5.15 (1H, dd, J = 9.0, 15.5 Hz, H-22), 
5.72 (1H, s, H-4). 13C NMR (100 MHz, CDCl3): δ 
11.9 (C-29), 12.1 (C-18), 17.3 (C-19), 18.9 (C-26), 
21.0 (C-11), 21.1 (C-27), 21.1 (C-21), 24.2 (C-15), 
25.4 (C-28), 29.7 (C-25), 31.8 (C-7), 32.0 (C-6), 
33.9 (C-2), 35.6 (C-1), 35.6 (C-8), 38.6 (C-10), 
39.5 (C-12), 40.4 (C-20), 42.2 (C-13), 51.2 (24), 
53.8 (C14), 55.8 (C-9), 55.9 (C-17), 123.7 (C-4), 
129.4 (C-23), 138.1 (C-22), 171.8 (C-5), 199.7 (C-
3). 
Compound 3: yield, 21 mg; 1HNMR (400 
MHz, CDCl3): δ 0.88 (3H, t, J = 6.4 Hz, H-21), 
1.27 (2H, overlapping, H-20), 1.60 (2H, 
overlapping, H-2), 3.68 (2H, t, J = 6.4 Hz, H-1). 
13C NMR (100 MHz, CDCl3): δ 14.1 (C-21), 23.7 
(C-20), 31.9 (C-19), 63.1 (C-1).   
Compound 4: yield, 25 mg; 1HNMR (400 
MHz, CDCl3): δ 0.88 (6H, t, J = 6.8 Hz, H-21/6’), 
1.65 (2H, overlapping, H-3/2’), 2.33 (2H, t, J = 6.8 
Hz, H-2), 4.09 (2H, t, J = 6.8 Hz, H1’), 13C NMR 
(100 MHz, CDCl3): δ 14.1 (C-21/6’), 22.7 (C-
20/5’), 25.0 (C-3), 25.9 (C-2’), 28.6 (C-3’), 31.9 
(C-19/4’), 34.4 (C-2), 64.4 (C-1’), 174.0 (C=O).   
  
RESULT AND DISCUSSION  
The 1H NMR spectrum data of compound 
1 showed a well resolved multiplet at the low-field 
region and a complicated resonance signals in the 
high-field region, which suggested a steroid 
skeleton. A pair of doublet of doublets signals at δH 
5.20 and 5.06; a doublet signal at δH 5.38 and a 
multiplet signal at δH 3.57 strongly suggested 
compound 1 to be a phytosterol (Forgo and Kover, 
2004). The signals at δH 5.20, and 5.06 (1H, dd, J = 
8.8, 15.2 Hz) were assigned to the olefinic protons 
at H-22 and H-23 respectively, while signal at δH 
5.38 (1H, d, J = 5.2 Hz), was attributed to olefinic 
proton (H-6). The multiplet signal at δH 3.57 
represented the proton located at position C-3. The 
highly overlapped signals in the upfield region, 
contain the six methyl signals. The COSY 
spectrum analysis showed the 1H-1H interaction 
between H-22 (δH 5.20) and H-23 (δH 5.06). The 
13C NMR spectrum revealed the total of 29 
carbons. The DEPT spectra analysis confirmed the 
presence of six methyl groups, three methylene 
groups, an olefinic quaternary carbon and one 
oxygenated carbon. Compound 1 was eventually 
identified as stigmas-5, 22-dien-3β-ol also known 
as stigmasterol, based on the comparison of its 
NMR data with those of stigmasterol previously 
reported (Forgo and Kover, 2004). 
Compound 3 was obtained as white solid. 
The 1H NMR spectrum (CDCl3, 400 MHz) 
displayed triplet signals at δH 3.68 assignable to the 
methyl group carrying the hydroxyl group. Triplet 
signal at δH 0.88 was attributed to the terminal 
methyl protons. The 1H-1H COSY spectrum 
indicated correlation between H-1 and H-2; 
between H-21 and H-22. Thus, H-2 proton signal 
was observed on the 1H NMR spectrum to overlap 
at δH 1.58, while H-20 proton signal overlapped at 
δH 1.27. The HMQC spectrum showed correlation 
between H-21 and C-21; between H-1 and C-1. 
Thus signal at δC 14.1 and 63.1 on the 13C NMR 
spectrum were assigned to C-21 and C-1 
respectively. The long-range 1H-13C HMBC 
spectrum indicated cross peaks linking H-21 to C-
19 and C-20. Hence, signals at δC 31.9 and 22.7 on 
the 13C NMR spectrum were assigned to C-19 and 
C-20 respectively. The DEPT spectrum further 
confirmed C-21 as sp3 carbon atom.  Compound 3 
was elucidated as 1-heneicosanol (3), based on the 
1D and 2D NMR spectra analysis and the data 
obtained were in agreement with those from 
literature (Luz et. al., 2016).  
Compound 4 was isolated as white solid 
substance. The 1H NMR spectrum data of 
compound 4 showed triplet signal at δH 4.06 
assigned to the oxo-methylene protons. Similarly, 
triplet signal at δH 2.29 was attributed to the 
methylene protons alpha to the carbonyl carbon. 
The triplet signal upfield at δH 0.88 was assigned to 
the terminal methyl protons in compound 3. From 
the 2D NMR analysis of compound 3, the COSY 
spectrum data showed correlation between H-1’ 
and H-2’; between H-2 and H-3; between H-20 and 
H-21; between H-6’ and H-5’. From these 
correlations, it is obvious that H-2’ and H-3 protons 
overlapped as observed in the 1H NMR spectra of 
compound 4 at δH 1.65. The HMQC spectrum 
revealed the 1H - 13C correlation between H-21/H6’ 
and C-21/C-6’; between H-2 and C-2. Thus, from 
the 13C NMR spectrum, C-2, C-21 and C-6’ were 
assigned at δC 34.4, 14.1 and 14.1 respectively. 
Furthermore, analysis of the HMBC spectrum of 
compound 4 showed cross peaks linking H-1’ to C-
2’; H-2 to C-3; H-21 to C-20 and C-19; H-6’ to C-
5’ and C-4’; H-1’ to C=O and H-2 to C=O. 
Therefore, the 13C NMR spectrum signal at δ 25.9, 
25.0, 22.7,, 22.7, 31.9, 31.9 and 174.0 were 
assigned to C-2’, C-3, C-20, C-5’, C-19, C-4’, and 
C=O respectively. The DEPT spectrum indicated 
the presence of one carbonyl carbon while DEPT 
spectrum confirmed the presence of sp3 carbon (C-
21 and C-6’). Based on the 1D and 2D NMR 
spectra analysis and comparison with those 
previously reported in literature (Niko and Dragan, 
2014), compound 4 was established as hexyl 
heneicosanoate (4).    
Compound 2a (stigmast-4-en-3-one) and 
Compound 2b (stigmast-4, 22-dien-3-one) were 
obtained as white solid mixture. The 1H and 13C 
NMR spectra data (Table 1) depicted mixture of 
stigmast-4-en-3-one (2a) and stigmast-4, 22-dien-
3-one (2b). The 1H NMR revealed signals 
representing six methyl groups at δH 1.18, 0.92, 
0.85, 0.84, 0.82, 0.71 and one olefinic proton at δH 
5.72.The 13C NMR spectrum data displayed 29 
carbon atom signals consisting of two olefinic 
carbons at δC 123.8 and 171.7 and carbonyl carbon 
at δ 199.7. The DEPT spectrum further confirmed 
the presence of carbonyl carbon. These NMR 
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spectra data suggests stigmast-4-ene-3-one (2a) 
structure. Furthermore, signals from the 1H NMR 
spectrum revealed three olefinic protons at δ 5.72, 
5.15, 5.03 and six methyl protons. The 13C NMR 
spectrum still accounted for another 29 carbon 
atoms with four olefinic carbons. The HMBC 
spectrum revealed 1H-13C correlation between H-
22/C-22 and H-23/C-23. The HMQC spectrum 
further showed correlations between H-4 with C-6 
and C-10, while H-22 and H-23 correlated with C-
20/21/24 and C-20 respectively. Hence, this data 
was attributed to stigmast-4, 22-dien-3-one (2b). 
From the NMR spectra analysis and comparison of 
the data with literatures (N.T. Hoa, 2014), it was 
obvious that stigmast-4-en-3-one (2a) and 
stigmasta-4,22-dien-3-one (2b) have been isolated 
as a mixture. 
 
Table 1: 1H and 13C NMR spectroscopic data for compound 2a and 2b in CDCl3 
 
Position of C 
Compound 2a Compound 2b 
δC δH  
(m, J in Hz) 
δC δH 
 (m, J in Hz) 
1 35.616  35.616  
2 33.987  33.987  
3 199.768  199.768  
4 123.736 5.72 (1H, s) 123.736 5.72 (1H, s) 
5 171.839  171.800  
6 33.875  32.035  
7 32.963  31.879  
8 35.684  35.684  
9 53.831  55.889  
10 38.622  38.622  
11 21.108  21.017  
12 39.620  39.519  
13 42.391  42.275  
14 55.878  53.813  
15 24.194  24.254  
16 28.204  28.881  
17 55.986  55.986  
18 12.262 0.71 (3H, s) 12.147 0.73 (3H, s) 
19 17.388 1.18 (3H, s) 17.388 1.18 (3H, s) 
20 36.122  40.490  
21 18.709 0.92 (3H, d, J = 6.5 
Hz) 
21.169 1.02 (3H, d, J = 7.5 
Hz) 
22 32.047  138.139 5.15 (1H, dd, J = 8.8, 
15.5 Hz) 
23 26.045  129.445 5.03 (1H, dd, J = 8.8, 
15.5 Hz) 
24 45.818  51.237  
25 29.132  29.714  
26 19.833 0.84 (3H, d, J = 6.8 
Hz) 
18.989 0.80 (3H, d, J = 6.0) 
27 19.025 0.82 (3H, d, J = 6.8 
Hz) 
21.108 0.85 (3H, d, J = 6.0 
Hz) 
28 23.060  25.413  
29 11.957 0.85 (3H,m) 11.983 0.81 (3H,m) 
 
CONCLUSION  
The extraction of leaf of C. singueana in 
n-hexane and the subsequent fractionation and 
purification of the crude n-hexane extract has 
afforded three steroids (stigmasterol (1), stigmast-
4-en-3one (2a) and stigmast-4,22-dien-3-one (2b)) 
and two fatty acid derivative compounds (1-
heneicosanol (3) and hexyl heneicosanoate (4)). 
These compounds as an entity or in synergy could 
be responsible for the ethno-medicinal/bioactivities 
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